News for 'SAR technologies'

Mission Drishti Marks Space Tech Breakthrough

Mission Drishti Marks Space Tech Breakthrough

Rediff.com4 May 2026

Weighing 190 kg, Mission Drishti is India's heaviest privately developed Earth observation satellite.

GalaxEye Plans 300 Kg Satellites

GalaxEye Plans 300 Kg Satellites

Rediff.com6 Mar 2026

'Today, as I look at our satellite -- tested, finished and ready to ship -- represents 1,642 days of grit and belief.'

Is GalaxEye's Mission Drishti Satellite Okay?

Is GalaxEye's Mission Drishti Satellite Okay?

Rediff.com12 May 2026

Concerns are rising about the status of GalaxEye Space's Mission Drishti, India's first Made in India OptoSAR satellite, launched on May 3. Reports suggest the satellite is tumbling in space, and experts highlight potential issues with solar panel deployment and stabilisation. The company has remained silent on the matter, fueling further speculation.

NISAR, Most Expensive Earth Satellite

NISAR, Most Expensive Earth Satellite

Rediff.com30 Jul 2025

The imaging technology in Nisar can provide very high-resolution data on changes as small as one centimetre in size on the earth's surface.

Pixxel to build India's 1st private Earth observation satellite

Pixxel to build India's 1st private Earth observation satellite

Rediff.com13 Aug 2025

The private consortium would invest more than Rs 1,200 crore over the next five years to launch a constellation of 12 state-of-the-art Earth Observation satellites equipped with panchromatic, multispectral, hyperspectral, and microwave SAR (synthetic aperture radar) sensors.

After NISAR mission, ISRO to launch 6,500 kg US satellite

After NISAR mission, ISRO to launch 6,500 kg US satellite

Rediff.com10 Aug 2025

ISRO to launch a 6,500 kg communication satellite built by the US, marking a significant milestone in the Indian space program after the successful launch of the NASA-ISRO NISAR mission.

ISRO to test space farming in next mission

ISRO to test space farming in next mission

Rediff.com22 Dec 2024

Demonstration of seed germination in outer space, a robotic arm to catch a tethered debris there, and testing of green propulsion systems are some of the experiments planned on the POEM-4 -- the fourth stage of ISRO's PSLV rocket that remains in orbit after launching a satellite.

Anlakhya, India's Defence Game Changer

Anlakhya, India's Defence Game Changer

Rediff.com28 Nov 2024

IIT Kanpur has announced a breakthrough in stealth technology, which would make tanks and fighter aircraft invisible, or near-invisible to enemy radar.

Mobile radiation: Phones with low and high SAR

Mobile radiation: Phones with low and high SAR

Rediff.com10 Jun 2011

Get Ahead reader Rohit Sane lists out mobile phones with low and high specific absorption rate (SAR) values in response to our reader invite (bleow). Phones with low SAR are considered good to use as they emit less radiations compared to phones with high SAR values.

SARS-CoV-2 alters lung cell metabolism: IIT Kharagpur

SARS-CoV-2 alters lung cell metabolism: IIT Kharagpur

Rediff.com14 Apr 2021

The research would lead to a better understanding of metabolic reprogramming and aid the development of better therapeutics to deal with the viral pandemics, an institute spokesperson said on Wednesday.

And now, a computer virus named SARS

And now, a computer virus named SARS

Rediff.com5 May 2003

Computers are likely to fall prey to a mass mailing worm 'SARS', also known as W32/Coronex-A, which attacks the address books and attempts to dupe users.

India to launch 7 Singapore satellites from Sriharikota on July 30

India to launch 7 Singapore satellites from Sriharikota on July 30

Rediff.com24 Jul 2023

Once deployed and operational, it will be used to support the satellite imagery requirements of various agencies within the government of Singapore.

COVID-19 Kills 1,700 People Globally A Week

COVID-19 Kills 1,700 People Globally A Week

Rediff.com28 Aug 2024

WHO has urged people at risk to keep up with their vaccinations with boosters.

New all-in-one vaccine may prove effective against all coronaviruses

New all-in-one vaccine may prove effective against all coronaviruses

Rediff.com7 May 2024

The research published in 'Nature Nanotechnolog' on Monday is based on a new approach to vaccine development called "proactive vaccinology", where scientists build a vaccine before the disease-causing pathogen even emerges, which has shown promising results in mice.

Covid: Parl panel stresses swift strategy evolution for next-gen vaccines

Covid: Parl panel stresses swift strategy evolution for next-gen vaccines

Rediff.com20 Dec 2023

The ICMR-National Institute of Virology has been regularly undertaking studies to understand the protective efficacy of COVID-19 vaccines against emerging variants.

India plans to launch 50 spy satellites in 5 years: ISRO chief

India plans to launch 50 spy satellites in 5 years: ISRO chief

Rediff.com29 Dec 2023

'Techfest', an annual science and technology event organised by the Indian Institute of Technology Bombay in Mumbai.

PSLV-C56 successfully places 7 Singaporean satellites into orbit

PSLV-C56 successfully places 7 Singaporean satellites into orbit

Rediff.com30 Jul 2023

Around 23 minutes after lift-off, the primary satellite got separated and it was followed by six other co-passenger satellites, which were deployed into the intended orbits sequentially, ISRO said.

How researchers detected Joshimath sinking

How researchers detected Joshimath sinking

Rediff.com14 Jan 2023

The PSInSAR satellite technique used to observe the gradual sinking of Uttarakhand's Joshimath town is a powerful remote sensing tool capable of measuring and monitoring displacements in the Earth's surface over time.

New test can predict your level of immunity against COVID-19

New test can predict your level of immunity against COVID-19

Rediff.com10 Aug 2022

Easy access to this kind of test could help people determine what kind of precautions they should take against COVID-19 infection, such as getting an additional booster shot, the researchers said.

ISRO successfully launches 2 Singapore satellites into orbit

ISRO successfully launches 2 Singapore satellites into orbit

Rediff.com22 Apr 2023

The primary satellite TeLEOS-2 is a synthetic aperture radar satellite developed under partnership between Defence Science and Technology Agency (DSTA) representing the Government of Singapore and ST Engineering.

Scientists developing chewing gum that could reduce Covid spread

Scientists developing chewing gum that could reduce Covid spread

Rediff.com6 Dec 2021

The researchers noted that people who are fully vaccinated can still become infected with SARS-CoV-2 and can carry a viral load similar to those who are unvaccinated.

India's Feluda COVID test cheaper alternative to RT-PCR, say scientists

India's Feluda COVID test cheaper alternative to RT-PCR, say scientists

Rediff.com28 Sep 2020

Named after Satyajit Ray's famed detective, the Feluda test, which is priced at Rs 500 and can deliver a result in 45 minutes, is able to differentiate SARS-CoV-2 from other coronaviruses even if genetic variations between them are minute.

ISRO successfully launches PSLV-C53 with 3 Singapore satellites onboard

ISRO successfully launches PSLV-C53 with 3 Singapore satellites onboard

Rediff.com30 Jun 2022

On Thursday, the four-stage, 44.4 metre tall PSLV-C53 that blasted off from the second launch pad of Satish Dhawan Space Centre and placed the three Singapore satellites--DS-EO, NeuSAR and SCOOB-1 in intended orbit.

Indemnity demands from pharma firms hit foreign Covid vaccine buy: Mandaviya

Indemnity demands from pharma firms hit foreign Covid vaccine buy: Mandaviya

Rediff.com25 Jun 2023

He also said that it was wrong to suggest that India stopped foreign made vaccines like that made by Moderna and Pfizer from coming to India.

India's vaccine makers prepare to take on Omicron

India's vaccine makers prepare to take on Omicron

Rediff.com8 Dec 2021

As the Omicron variant of Sars-CoV-2 takes centrestage, vaccine makers in India are of the view that scaling up the existing vaccines to make them more effective is possible.

Zydus Cadila starts supply of COVID-19 vaccine to govt

Zydus Cadila starts supply of COVID-19 vaccine to govt

Rediff.com2 Feb 2022

ZyCoV-D is a three-dose vaccine administered intradermally.

New COVID-19 test can give results in just 45 minutes

New COVID-19 test can give results in just 45 minutes

Rediff.com29 Apr 2020

The test named the "SARS-CoV-2 DETECTR" is easy to implement and to interpret, and requires no specialised equipment, said researchers from the University of California, San Francisco in the US.

New low-cost test can diagnose COVID-19 in just 20 minutes

New low-cost test can diagnose COVID-19 in just 20 minutes

Rediff.com14 Aug 2020

The rapid molecular test is highly accurate and easy to use, making it a prime candidate for use in settings with limited testing capabilities, according to the researchers.

DCGI approves commercial launch of low-cost Covid test 'Feluda'

DCGI approves commercial launch of low-cost Covid test 'Feluda'

Rediff.com20 Sep 2020

This test uses an indigenously developed, cutting-edge CRISPR technology for detection of the genomic sequence of SARS-CoV-2 virus, CSIR said in a statement.

After 15 months, RBI allows AmEx to acquire new credit card customers

After 15 months, RBI allows AmEx to acquire new credit card customers

Rediff.com25 Aug 2022

The Reserve Bank of India has on Wednesday lifted the ban on new customer acquisition by American Express which was imposed with effect from May 2021 due to non-compliance with local data storage norms. "In view of the satisfactory compliance demonstrated by American Express Banking Corp. with the Reserve Bank of India (RBI) circular dated April 6, 2018, on Storage of Payment System Data, the restrictions imposed, vide order dated April 23, 2021, on onboarding of new domestic customers have been lifted with immediate effect," RBI said. Similar bans were imposed on Diners Club International and Mastercard previously.

Coming Soon, New Ways To Vaccinate

Coming Soon, New Ways To Vaccinate

Rediff.com3 Sep 2022

'Just put a patch on your arm and the vaccine can be absorbed by the body.'

SARS may hit Infosys' China plan

SARS may hit Infosys' China plan

Rediff.com16 May 2003

Infosys Technologies Ltd said that its plan to enter China may have hit a roadblock due to the current outbreak of Severe Acute Respiratory Syndrome.

India's 1st Covid nasal vax gets phase 2 trial nod

India's 1st Covid nasal vax gets phase 2 trial nod

Rediff.com13 Aug 2021

The first nasal vaccine against COVID-19, developed by Bharat Biotech, has received regulator's nod for conducting phase 2 clinical trials, the Department of Biotechnology said on Friday.

Researchers develop new N95 mask that can curb Covid spread, kill virus

Researchers develop new N95 mask that can curb Covid spread, kill virus

Rediff.com4 Jul 2022

The mask can potentially be worn longer, causing less plastic waste as it does not need to be replaced as frequently, the researchers said.

Centre remains on high-alert for new Covid variants

Centre remains on high-alert for new Covid variants

Rediff.com20 Jun 2023

COVID-19 is on the verge of becoming endemic but Indian scientists are keeping a close watch on each new variant and the government would continue to maintain a high alert, Union health minister Mansukh Mandaviya has said, underlining that the virus has managed to survive and is going to stay.

Covaxin output scaled up to 500 million jabs a year: Bharat Biotech

Covaxin output scaled up to 500 million jabs a year: Bharat Biotech

Rediff.com17 May 2021

This apart, to further increase capacities, Bharat Biotech has partnered with Indian Immunologicals (IIL) to manufacture the drug substance for Covaxin. The technology transfer process is underway and IIL has the 'capabilities and expertise' to manufacture the inactivated viral vaccines at commercial scale.

'COVID-19 vaccine will be made in India'

'COVID-19 vaccine will be made in India'

Rediff.com12 Jun 2020

'I can say with confidence that any future SARS-CoV-2 vaccine, developed anywhere in the world, would have to be manufactured in India, if it is to be affordable and of high quality.'

Covid vax don't give total protection: WHO scientist

Covid vax don't give total protection: WHO scientist

Rediff.com12 Aug 2021

"Even though the vaccine may not be able to provide absolute protection against different variants of virus, it can certainly reduce the risk of death and complications," a statement quoting WHO chief scientist Soumya Swaminathan said.

'None of the existing vaccines can prevent emerging variants of Omicron'

'None of the existing vaccines can prevent emerging variants of Omicron'

Rediff.com25 Jan 2023

'We seem to be in a situation where we can do little, and nothing needs to be done anyway.'